These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 26179583)

  • 41. The creation of innovation through public-private collaboration.
    Esteve M; Ysa T; Longo F
    Rev Esp Cardiol (Engl Ed); 2012 Sep; 65(9):835-42. PubMed ID: 22771082
    [TBL] [Abstract][Full Text] [Related]  

  • 42. When do developing countries adopt managed care policies and technologies? Part II: Infrastructure, techniques, and reform strategies.
    Luck J; Peabody JW
    Am J Manag Care; 2002 Dec; 8(12):1093-103. PubMed ID: 12500885
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The comparative advantage of NGO (non-governmental organizations) in the health sector--a look at the evidence.
    Matthias AR; Green AT
    World Hosp Health Serv; 1994; 30(1):10-5. PubMed ID: 10135089
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Open innovation and external sources of innovation. An opportunity to fuel the R&D pipeline and enhance decision making?
    Schuhmacher A; Gassmann O; McCracken N; Hinder M
    J Transl Med; 2018 May; 16(1):119. PubMed ID: 29739427
    [TBL] [Abstract][Full Text] [Related]  

  • 45. What restructuring means for nurses in Denmark.
    Stallknecht K; Jespersen PH
    Int Nurs Rev; 1996; 43(1):9-12. PubMed ID: 8707515
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The concept of marketing in the public-private partnership in the medical system in Romania.
    Purcărea VL; Coculescu BI; Coculescu EC
    J Med Life; 2014; 7 Spec No. 3(Spec Iss 3):20-2. PubMed ID: 25870689
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Saving American health care.
    Klepper BR; Hayes PG; Brown JB
    J Ambul Care Manage; 2002 Jul; 25(3):34-40. PubMed ID: 12141017
    [TBL] [Abstract][Full Text] [Related]  

  • 48. States' rights. Public-private collaborations statewide could further boost healthcare into the future.
    Wine M; Groen P
    Healthc Inform; 2005 Aug; 22(8):37-8. PubMed ID: 16173636
    [No Abstract]   [Full Text] [Related]  

  • 49. [The health system of Costa Rica].
    Sáenz Mdel R; Acosta M; Muiser J; Bermúdez JL
    Salud Publica Mex; 2011; 53 Suppl 2():s156-67. PubMed ID: 21877081
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Enhancing Private Sector Health System Preparedness for 21st-Century Health Threats: Foundational Principles From a National Academies Initiative.
    Berwick DM; Shine K
    JAMA; 2020 Mar; 323(12):1133-1134. PubMed ID: 32207806
    [No Abstract]   [Full Text] [Related]  

  • 51. Reinventing R&D in an open innovation ecosystem.
    Traitler H; Watzke HJ; Saguy IS
    J Food Sci; 2011 Mar; 76(2):R62-8. PubMed ID: 21535785
    [TBL] [Abstract][Full Text] [Related]  

  • 52. When do developing countries adopt managed care policies and technologies? Part I: Policies, experience, and a framework of preconditions.
    Peabody JW; Luck J
    Am J Manag Care; 2002 Nov; 8(11):997-1007. PubMed ID: 12437314
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Schrödinger's pipeline and the outsourcing of pharmaceutical innovation.
    McMeekin P; Lendrem DW; Lendrem BC; Pratt AG; Peck R; Isaacs JD; Jones D
    Drug Discov Today; 2020 Mar; 25(3):480-484. PubMed ID: 31835019
    [TBL] [Abstract][Full Text] [Related]  

  • 54. How shall we examine and learn about public-private partnerships (PPPs) in the health sector? Realist evaluation of PPPs in Hong Kong.
    Wong EL; Yeoh EK; Chau PY; Yam CH; Cheung AW; Fung H
    Soc Sci Med; 2015 Dec; 147():261-9. PubMed ID: 26605970
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Health care and health innovation in Europe: regulating for public benefit or for commercial profit?
    Warren-Jones A
    Health Econ Policy Law; 2017 Oct; 12(4):403-409. PubMed ID: 28414005
    [No Abstract]   [Full Text] [Related]  

  • 56. The role of oversight in the health sector: the example of sexual and reproductive health services in India.
    Peters DH
    Reprod Health Matters; 2002 Nov; 10(20):82-94. PubMed ID: 12557645
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Applying a Total Market Lens: Increased IUD Service Delivery Through Complementary Public- and Private-Sector Interventions in 4 Countries.
    White JN; Corker J
    Glob Health Sci Pract; 2016 Aug; 4 Suppl 2(Suppl 2):S21-32. PubMed ID: 27540122
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role of Public-Private Partnerships in Meeting Healthcare Challenges in Africa: A Perspective From the Private Sector.
    Cohen G
    J Infect Dis; 2016 Apr; 213 Suppl 2(Suppl 2):S33. PubMed ID: 27025694
    [No Abstract]   [Full Text] [Related]  

  • 59. Private health care sector investment in Brazil: opportunities and obstacles.
    Brandt R
    World Hosp Health Serv; 2003; 39(1):11-4, 30, 32. PubMed ID: 12743882
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Private Sector An Important But Not Dominant Provider Of Key Health Services In Low- And Middle-Income Countries.
    Grépin KA
    Health Aff (Millwood); 2016 Jul; 35(7):1214-21. PubMed ID: 27385236
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.